Skip to main content

Table 1 Types of biomarkers for AIT

From: Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies

Identification and validation of biomarkers assessing the probability of response to treatment of AIT before it is initiated
Identification and validation of biomarkers assessing the safety of AIT before it is initiated
Identification and validation of biomarkers confirming the efficacy of AIT in patients receiving AIT (short and long term)
Identification and validation of biomarkers predicting the long-term effects of AIT before it is stopped
Identification and validation of biomarkers predicting the relapse of symptoms when AIT is stopped